Skip Nav Destination
Issues
June 2011
ISSN 0030-2414
EISSN 1423-0232
Journal Name Change
Vol. 1-20 (1948-1966) were published under the journal's former title Oncologia.
Oncology 2011, Vol. 80, No. 1-2
Review
New Strategies for Medical Management of Castration-Resistant Prostate Cancer
Subject Area:
Oncology
Irène Asmane; Jocelyn Céraline; Brigitte Duclos; Lynn Rob; Valère Litique; Philippe Barthélémy; Jean-Pierre Bergerat; Patrick Dufour; Jean-Emmanuel Kurtz
Oncology (2011) 80 (1-2): 1–11.
https://doi.org/10.1159/000323495
Clinical Translational Research
Progression-Free Survival in Ovarian Cancer Is Reflected in Epigenetic DNA Methylation Profiles
Subject Area:
Oncology
Dirk O. Bauerschlag; Ole Ammerpohl; Karen Bräutigam; Christian Schem; Qiong Lin; Marion T. Weigel; Felix Hilpert; Norbert Arnold; Nicolai Maass; Ivo Meinhold-Heerlein; Wolfgang Wagner
Oncology (2011) 80 (1-2): 12–20.
https://doi.org/10.1159/000327746
Clinical Study
Analysis of Prognostic Factors of Pediatric-Type Sarcomas in Adult Patients
Subject Area:
Oncology
Hee Kyung Ahn; Ji Eun Uhm; Jeeyun Lee; Do Hoon Lim; Sung Wook Seo; Ki-Sun Sung; Su Jin Lee; Duk Joo Lee; Kyung Kee Baek; Won-Seog Kim; Joon Oh Park
Oncology (2011) 80 (1-2): 21–28.
https://doi.org/10.1159/000327222
Self-Reported Compliance with Capecitabine: Findings from a Prospective Cohort Analysis
Subject Area:
Oncology
Ralph Winterhalder; Pierre Hoesli; Geoffrey Delmore; Stefanie Pederiva; Albéric Bressoud; Frank Hermann; Roger von Moos; on behalf of the SAEDA Investigators Group (Swiss prospective cohort group)
Oncology (2011) 80 (1-2): 29–33.
https://doi.org/10.1159/000328317
Efficacy of Temsirolimus after Previous Treatment with Sunitinib, Sorafenib or Everolimus in Advanced Renal Cell Cancer
Subject Area:
Oncology
Michael Grundbichler; Brigitte Mlineritsch; Sigrun Ressler; Martin Moik; Andrea Kappacher; Sabine Rosenlechner; Richard Greil
Oncology (2011) 80 (1-2): 34–41.
https://doi.org/10.1159/000328086
Incidence of Non-AIDS-Defining Cancer in Antiretroviral Treatment-Naïve Subjects after Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials Analysis
Subject Area:
Oncology
Supriya Krishnan; Jeffrey T. Schouten; Denise L. Jacobson; Constance A. Benson; Ann C. Collier; Susan L. Koletar; Jorge Santana; Fred R. Sattler; Ronald Mitsuyasu; for the ACTG-ALLRT Protocol Team
Oncology (2011) 80 (1-2): 42–49.
https://doi.org/10.1159/000328032
A Phase I Study of the Safety and Pharmacokinetics of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma
Subject Area:
Oncology
Kristen N. Ganjoo; Lee D. Cranmer; James E. Butrynski; Daniel Rushing; Douglas Adkins; Scott H. Okuno; Gustavo Lorente; Stew Kroll; Virginia K. Langmuir; Sant P. Chawla
Oncology (2011) 80 (1-2): 50–56.
https://doi.org/10.1159/000327739
Prognostic Relevance of Circulating Tumor Cells in Metastatic Uveal Melanoma
Subject Area:
Oncology
R. Schuster; N.E. Bechrakis; A. Stroux; A. Busse; A. Schmittel; E. Thiel; M.H. Foerster; U. Keilholz
Oncology (2011) 80 (1-2): 57–62.
https://doi.org/10.1159/000328283
Long-Term Outcome of Combined Interferon-α and 5-Fluorouracil Treatment for Advanced Hepatocellular Carcinoma with Major Portal Vein Thrombosis
Subject Area:
Oncology
Hiroaki Nagano; Hiroshi Wada; Shogo Kobayashi; Shigeru Marubashi; Hidetoshi Eguchi; Masahiro Tanemura; Yoshito Tomimaru; Keigo Osuga; Koji Umeshita; Yuichiro Doki; Masaki Mori
Oncology (2011) 80 (1-2): 63–69.
https://doi.org/10.1159/000328281
Phase II Study of Combined Treatment with Irinotecan and S-1 (IRIS) in Patients with Inoperable or Recurrent Advanced Colorectal Cancer (HGCSG0302)
Subject Area:
Oncology
Yoshito Komatsu; Satoshi Yuki; Susumu Sogabe; Hiraku Fukushima; Ichiro Iwanaga; Mineo Kudo; Miki Tateyama; Takashi Meguro; Minoru Uebayashi; Akiyoshi Saga; Yuh Sakata; Masahiro Asaka
Oncology (2011) 80 (1-2): 70–75.
https://doi.org/10.1159/000328739
A Phase II Multi-Center Study of Triple Therapy with Paclitaxel, S-1 and Cisplatin in Patients with Advanced Gastric Cancer
Subject Area:
Oncology
Oncology (2011) 80 (1-2): 76–83.
https://doi.org/10.1159/000328746
FOLFOX as Adjuvant Chemotherapy after Curative Resection of Distant Metastases in Patients with Colorectal Cancer
Subject Area:
Oncology
Hiroaki Nozawa; Joji Kitayama; Eiji Sunami; Shinsuke Saito; Takamitsu Kanazawa; Shinsuke Kazama; Kentaro Yazawa; Kazushige Kawai; Ken Mori; Hirokazu Nagawa
Oncology (2011) 80 (1-2): 84–91.
https://doi.org/10.1159/000328761
Clinical Translational Research
Time-Course Studies of Implanted Rabbit VX2 Liver Tumors to Identify the Appropriate Time for Starting Hepatic Arterial Embolization in Animal Models
Subject Area:
Oncology
Akinaga Sonoda; Norihisa Nitta; Ayumi Nitta-Seko; Shinichi Ohta; Yukihiro Nagatani; Kenichi Mukaisho; Hideji Otani; Keiko Tsuchiya; Masashi Takahashi; Kiyoshi Murata
Oncology (2011) 80 (1-2): 92–96.
https://doi.org/10.1159/000328763
Clinical Study
Gemcitabine and Oxaliplatin Combination Chemotherapy for Patients with Refractory Pancreatic Cancer
Subject Area:
Oncology
Hiroyuki Isayama; Yousuke Nakai; Keisuke Yamamoto; Takashi Sasaki; Suguru Mizuno; Hiroshi Yagioka; Yoko Yashima; Kazumichi Kawakubo; Hirofumi Kogure; Toshihiko Arizumi; Osamu Togawa; Yukiko Ito; Saburo Matsubara; Natsuyo Yamamoto; Naoki Sasahira; Kenji Hirano; Takeshi Tsujino; Minoru Tada; Masao Omata; Kazuhiko Koike
Oncology (2011) 80 (1-2): 97–101.
https://doi.org/10.1159/000328767
Carcinosarcoma of the Ovary: Analysis of 13 Cases and Review of the Literature
Subject Area:
Oncology
Vera Loizzi; Gennaro Cormio; Anna Camporeale; Maddalena Falagario; Paola De Mitri; Doriana Scardigno; Giuseppe Putignano; Luigi E. Selvaggi
Oncology (2011) 80 (1-2): 102–106.
https://doi.org/10.1159/000328794
Comparison of Long-Term Outcome between Doublet and Triplet Neoadjuvant Chemotherapy in Non-Metastatic Osteosarcoma of the Extremity
Subject Area:
Oncology
Soojung Hong; Sang Joon Shin; Minkyu Jung; Jaeheon Jeong; Young Joo Lee; Kyoo-Ho Shin; Jae Kyung Roh; Sun Young Rha
Oncology (2011) 80 (1-2): 107–117.
https://doi.org/10.1159/000327216
Clinical Translational Research
End-of-Life Hospital Costs in Cancer Patients: Do Advance Directives or Routes of Hospital Admission Make a Difference?
Subject Area:
Oncology
Oncology (2011) 80 (1-2): 118–122.
https://doi.org/10.1159/000328279
Clinical Study
Therapeutic Outcomes of Papillary Thyroid Cancer Patients in Different Risk Groups
Subject Area:
Oncology
Oncology (2011) 80 (1-2): 123–129.
https://doi.org/10.1159/000328912
Clinical Translational Research
Prognostic Impact of Phosphorylated Mitogen-Activated Protein Kinase Expression in Patients with Metastatic Gastric Cancer
Subject Area:
Oncology
Akin Atmaca; Claudia Pauligk; Kristina Steinmetz; Hans-Michael Altmannsberger; Elke Jäger; Salah-Eddin Al-Batran
Oncology (2011) 80 (1-2): 130–134.
https://doi.org/10.1159/000329063
Letter to the Editor
Regarding ‘Treatment of Colorectal Cancer with and without Bevacizumab: A Phase III Study’
Subject Area:
Oncology
Oncology (2011) 80 (1-2): 135–137.
https://doi.org/10.1159/000327227
Comment on ‘Treatment of Colorectal Cancer with and without Bevacizumab: A Phase III Study’
Subject Area:
Oncology
Oncology (2011) 80 (1-2): 138–139.
https://doi.org/10.1159/000327237
Reply
Reply to Dr. Kabbinavar and Dr. Kozloff
Subject Area:
Oncology
Oncology (2011) 80 (1-2): 140–141.
https://doi.org/10.1159/000327226
Clinical Study
A Prognostic Model to Predict Clinical Outcome in Gastric Cancer Patients with Bone Metastasis
Subject Area:
Oncology
Hyung Soon Park; Sun Young Rha; Hyo Song Kim; Woo Jin Hyung; Ji Soo Park; Hyun Cheol Chung; Sung Hoon Noh; Hei-Cheul Jeung
Oncology (2011) 80 (1-2): 142–150.
https://doi.org/10.1159/000328507